SUPN 股东权益历史(2016–2025)
SUPERNUS PHARMACEUTICALS, INC. (SUPN) 各财年年末股东权益(来自 SEC 财报)。
$1.1BFY2025 · FY2016 以来:$191.8M → $1.1B
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $1.1B | +2.5% |
| FY2024 | $1.0B | +12.4% |
| FY2023 | $921.5M | +4.0% |
| FY2022 | $886.2M | +8.6% |
| FY2021 | $815.9M | +9.5% |
| FY2020 | $744.9M | +25.1% |
| FY2019 | $595.4M | +31.4% |
| FY2018 | $453.0M | +69.4% |
| FY2017 | $267.5M | +39.5% |
| FY2016 | $191.8M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议